Between January 1984 to June 1985, 18 Ph1 positive chronic myeloid leukemia (CML) patients in chronic phase (CP) underwent allogeneic bone marrow transplantation (BMT) from HLA identical and MLC negative siblings. The median age was 32.5 yr and median disease duration of CML at time of BMT was 19.3 months. The pretransplant conditioning regimen consisted of cyclophosphamide (CTX) (120 mg/kg) and 10.20 Gy total body irradiation (TBI) at 6 doses of 1.7 Gy each, administered in 3 daily fractions over 2 days at a dose rate of 15-20 cGy/min. To prevent graft-vs-host disease (GvHD) we used methotrexate (MTX) in one patient and cyclosporin-A (CYA) in the other 17 patients. In addition to CYA, given until day +365, 10 patients received donor marrow...
Cyclophosphamide (Cy) in combination with busulfan (Bu) or total body irradiation (TBI) is the most ...
AbstractCyclophosphamide (Cy) in combination with busulfan (Bu) or total body irradiation (TBI) is t...
The role of allogeneic transplantation in patients with de novo acute myeloid leukemia in first comp...
Between February 1981 and December 1984 we treated 52 patients with chronic myeloid leukemia in the ...
Between December 1983 and November 1985 we treated 39 patients with chronic myeloid leukaemia by che...
A prospective randomized study was conducted comparing two conditioning regimens for the treatment o...
One hundred fifteen patients with chronic myelocytic leuke-mia (CML) were administered busulphan 4 m...
One hundred and forty-six patients with acute leukaemia (81 with ANLL and 65 with ALL) received allo...
One hundred and forty-six patients with acute leukaemia (81 with ANLL and 65 with ALL) received allo...
There is no doubt that the poor reputation of T-cell depleted bone marrow transplant arises from its...
T-cell-depleted marrow grafts from unrelated donors as treatment for chronic myelogenous leukemia (C...
AbstractAlthough allogeneic transplantation is a curative therapy for chronic myeloid leukemia (CML)...
Background: Allogeneic hematopoietic stem cell transplantation (HSCT) has been considered for decade...
A total of 282 patients with leukemia have been treated by transplantation from HLA-matched siblings...
T-replete haploidentical donor transplants using posttransplant cyclophosphamide (haplo) have greatl...
Cyclophosphamide (Cy) in combination with busulfan (Bu) or total body irradiation (TBI) is the most ...
AbstractCyclophosphamide (Cy) in combination with busulfan (Bu) or total body irradiation (TBI) is t...
The role of allogeneic transplantation in patients with de novo acute myeloid leukemia in first comp...
Between February 1981 and December 1984 we treated 52 patients with chronic myeloid leukemia in the ...
Between December 1983 and November 1985 we treated 39 patients with chronic myeloid leukaemia by che...
A prospective randomized study was conducted comparing two conditioning regimens for the treatment o...
One hundred fifteen patients with chronic myelocytic leuke-mia (CML) were administered busulphan 4 m...
One hundred and forty-six patients with acute leukaemia (81 with ANLL and 65 with ALL) received allo...
One hundred and forty-six patients with acute leukaemia (81 with ANLL and 65 with ALL) received allo...
There is no doubt that the poor reputation of T-cell depleted bone marrow transplant arises from its...
T-cell-depleted marrow grafts from unrelated donors as treatment for chronic myelogenous leukemia (C...
AbstractAlthough allogeneic transplantation is a curative therapy for chronic myeloid leukemia (CML)...
Background: Allogeneic hematopoietic stem cell transplantation (HSCT) has been considered for decade...
A total of 282 patients with leukemia have been treated by transplantation from HLA-matched siblings...
T-replete haploidentical donor transplants using posttransplant cyclophosphamide (haplo) have greatl...
Cyclophosphamide (Cy) in combination with busulfan (Bu) or total body irradiation (TBI) is the most ...
AbstractCyclophosphamide (Cy) in combination with busulfan (Bu) or total body irradiation (TBI) is t...
The role of allogeneic transplantation in patients with de novo acute myeloid leukemia in first comp...